788 related articles for article (PubMed ID: 25777667)
1. Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials.
Palmerini T; Benedetto U; Bacchi-Reggiani L; Della Riva D; Biondi-Zoccai G; Feres F; Abizaid A; Hong MK; Kim BK; Jang Y; Kim HS; Park KW; Genereux P; Bhatt DL; Orlandi C; De Servi S; Petrou M; Rapezzi C; Stone GW
Lancet; 2015 Jun; 385(9985):2371-82. PubMed ID: 25777667
[TBL] [Abstract][Full Text] [Related]
2. Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation: an individual patient data pairwise and network meta-analysis.
Palmerini T; Sangiorgi D; Valgimigli M; Biondi-Zoccai G; Feres F; Abizaid A; Costa RA; Hong MK; Kim BK; Jang Y; Kim HS; Park KW; Mariani A; Della Riva D; Genereux P; Leon MB; Bhatt DL; Bendetto U; Rapezzi C; Stone GW
J Am Coll Cardiol; 2015 Mar; 65(11):1092-102. PubMed ID: 25790880
[TBL] [Abstract][Full Text] [Related]
3. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Bittl JA; Baber U; Bradley SM; Wijeysundera DN
J Am Coll Cardiol; 2016 Sep; 68(10):1116-39. PubMed ID: 27036919
[TBL] [Abstract][Full Text] [Related]
4. Shorter (≤6 months) versus longer (≥12 months) duration dual antiplatelet therapy after drug eluting stents: a meta-analysis of randomized clinical trials.
Pandit A; Giri S; Hakim FA; Fortuin FD
Catheter Cardiovasc Interv; 2015 Jan; 85(1):34-40. PubMed ID: 24753084
[TBL] [Abstract][Full Text] [Related]
5. Optimal Duration of Dual Antiplatelet Therapy after Drug-Eluting Stents: Meta-Analysis of Randomized Trials.
Abo-Salem E; Alsidawi S; Jamali H; Effat M; Helmy T
Cardiovasc Ther; 2015 Oct; 33(5):253-63. PubMed ID: 26010419
[TBL] [Abstract][Full Text] [Related]
6. Risk-Benefit Profile of Longer-Than-1-Year Dual-Antiplatelet Therapy Duration After Drug-Eluting Stent Implantation in Relation to Clinical Presentation.
Palmerini T; Bruno AG; Gilard M; Morice MC; Valgimigli M; Montalescot G; Collet JP; Della Riva D; Bacchi-Reggiani ML; Steg PG; Diallo A; Vicaut E; Helft G; Nakamura M; Généreux P; Vahl TP; Stone GW
Circ Cardiovasc Interv; 2019 Mar; 12(3):e007541. PubMed ID: 30871353
[TBL] [Abstract][Full Text] [Related]
7. Optimal Duration of Dual Antiplatelet Therapy After DES Implantation: A Meta-Analysis of 11 Randomized Trials.
Verdoia M; Schaffer A; Barbieri L; Montalescot G; Collet JP; Colombo A; Suryapranata H; De Luca G
Angiology; 2016 Mar; 67(3):224-38. PubMed ID: 26069031
[TBL] [Abstract][Full Text] [Related]
8. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
; Bittl JA; Baber U; Bradley SM; Wijeysundera DN
Circulation; 2016 Sep; 134(10):e156-78. PubMed ID: 27026019
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of antiplatelet regimens after percutaneous coronary intervention using drug eluting stents: A network meta-analysis of randomized controlled trials.
Garg A; Rout A; Sharma A; Sargsyan D; Beavers T; Tantry U; Gurbel P; Rao SV; Kostis JB; Cohen M
Prog Cardiovasc Dis; 2020; 63(3):243-248. PubMed ID: 32247786
[TBL] [Abstract][Full Text] [Related]
10. Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: Meta-analysis of randomized controlled trials.
Fei Y; Tsoi MF; Cheung TT; Cheung BM
Int J Cardiol; 2016 Oct; 220():895-900. PubMed ID: 27400191
[TBL] [Abstract][Full Text] [Related]
11. Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial.
Collet JP; Silvain J; Barthélémy O; Rangé G; Cayla G; Van Belle E; Cuisset T; Elhadad S; Schiele F; Lhoest N; Ohlmann P; Carrié D; Rousseau H; Aubry P; Monségu J; Sabouret P; O'Connor SA; Abtan J; Kerneis M; Saint-Etienne C; Beygui F; Vicaut E; Montalescot G;
Lancet; 2014 Nov; 384(9954):1577-85. PubMed ID: 25037988
[TBL] [Abstract][Full Text] [Related]
12. Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials.
Cassese S; Byrne RA; Tada T; King LA; Kastrati A
Eur Heart J; 2012 Dec; 33(24):3078-87. PubMed ID: 23091199
[TBL] [Abstract][Full Text] [Related]
13. Safety of an abbreviated duration of dual antiplatelet therapy (≤6 months) following second-generation drug-eluting stents for coronary artery disease: A systematic review and meta-analysis of randomized trials.
Ziada KM; Abdel-Latif AK; Charnigo R; Moliterno DJ
Catheter Cardiovasc Interv; 2016 Mar; 87(4):722-732. PubMed ID: 26309050
[TBL] [Abstract][Full Text] [Related]
14. Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: conceptual evolution based on emerging evidence.
Palmerini T; Stone GW
Eur Heart J; 2016 Jan; 37(4):353-64. PubMed ID: 26795933
[TBL] [Abstract][Full Text] [Related]
15. Duration of dual antiplatelet therapy following drug-eluting stent implantation: A systemic review and meta-analysis of randomized controlled trials with longer follow up.
Sharma A; Agrawal S; Garg A; Vallakati A; Lavie CJ; Helft G
Catheter Cardiovasc Interv; 2017 Jul; 90(1):31-37. PubMed ID: 28557264
[TBL] [Abstract][Full Text] [Related]
16. Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Sharma A; Hai O; Garg A; Vallakati A; Lavie CJ; Marmur JD
Curr Probl Cardiol; 2017 Dec; 42(12):404-417. PubMed ID: 29110813
[TBL] [Abstract][Full Text] [Related]
17. Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials.
Giustino G; Baber U; Sartori S; Mehran R; Mastoris I; Kini AS; Sharma SK; Pocock SJ; Dangas GD
J Am Coll Cardiol; 2015 Apr; 65(13):1298-1310. PubMed ID: 25681754
[TBL] [Abstract][Full Text] [Related]
18. Dual Antiplatelet Therapy Continuation Beyond 1 Year After Drug-Eluting Stents: A Meta-Analysis of Randomized Trials.
Ferrante G; Condorelli G; Pagnotta P; Reimers B
Circ Cardiovasc Interv; 2017 May; 10(5):. PubMed ID: 28500135
[TBL] [Abstract][Full Text] [Related]
19. Duration of Dual Antiplatelet Therapy in Patients with CKD and Drug-Eluting Stents: A Meta-Analysis.
Mavrakanas TA; Chatzizisis YS; Gariani K; Kereiakes DJ; Gargiulo G; Helft G; Gilard M; Feres F; Costa RA; Morice MC; Georges JL; Valgimigli M; Bhatt DL; Mauri L; Charytan DM
Clin J Am Soc Nephrol; 2019 Jun; 14(6):810-822. PubMed ID: 31010936
[TBL] [Abstract][Full Text] [Related]
20. Longer- Versus Shorter-Duration Dual-Antiplatelet Therapy After Drug-Eluting Stent Placement: A Systematic Review and Meta-analysis.
Spencer FA; Prasad M; Vandvik PO; Chetan D; Zhou Q; Guyatt G
Ann Intern Med; 2015 Jul; 163(2):118-26. PubMed ID: 26005909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
